163 related articles for article (PubMed ID: 38758423)
1. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients.
Erduran F; Adışen E; Emre S; Hayran Y; Başkan EB; Yazıcı S; Bilgiç A; Alpsoy E; Günaydın SD; Elmas L; Akyol M; Güner R; Arıca DA; Aypek Y; Ergun T; Karavelioğlu D; Yazıcı AC; Aydoğan K; Bayramgürler D; Kıran R; Erdoğan HK; Acer E; Aktaş A
Dermatol Ther (Heidelb); 2024 Jun; 14(6):1547-1560. PubMed ID: 38758423
[TBL] [Abstract][Full Text] [Related]
2. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
3. Clinico- Therapeutic Study of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis and Prognostic Significance of SCORTEN in Indian Patients.
Jangid NC; Choudhary AN; Shah BJ; Shah SR; Vyas HR; Mistry D
Indian J Dermatol; 2024; 69(1):24-31. PubMed ID: 38572027
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
5. Clinicoetiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Spectrum and the Correlation of SCORTEN with Prognosis.
Kanagarajan A; Murthy AB; Moni PK; Palanivel N
Indian J Dermatol; 2023; 68(1):25-33. PubMed ID: 37151260
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
7. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
9. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.
Roujeau JC; Bastuji-Garin S
Ther Adv Drug Saf; 2011 Jun; 2(3):87-94. PubMed ID: 25083204
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Miyamoto Y; Ohbe H; Kumazawa R; Matsui H; Fushimi K; Yasunaga H; Ohta B
JAMA Dermatol; 2023 May; 159(5):481-487. PubMed ID: 36884227
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients.
Rattanakaemakorn P; Palakornkitti P; Pinyowiwat P; Jedee P; Thadanipon K
Front Med (Lausanne); 2022; 9():939210. PubMed ID: 36091688
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study.
Kridin K; Brüggen MC; Chua SL; Bygum A; Walsh S; Nägeli MC; Kucinskiene V; French L; Tétart F; Didona B; Milpied B; Ranki A; Salavastru C; Brezinová E; Divani-Patel S; Lorentzen T; Nagel JL; Valiukeviciene S; Karpaviciute V; Tiplica GS; Oppel E; Oschmann A; de Prost N; Vorobyev A; Ingen-Housz-Oro S
JAMA Dermatol; 2021 Oct; 157(10):1182-1190. PubMed ID: 34431984
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Experience from a Tertiary Care Centre of South Rajasthan.
Balai M; Meena M; Mittal A; Gupta LK; Khare AK; Mehta S
Indian Dermatol Online J; 2021; 12(1):116-122. PubMed ID: 33768032
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.
Torres-Navarro I; Briz-Redón Á; Botella-Estrada R
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):159-171. PubMed ID: 32946187
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
